1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

iRadimed Corp (IRMD) Files 10-K for the Fiscal Year Ended on December 31, 2017

March 08, 2018 | About:

iRadimed Corp (NASDAQ:IRMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. iRadimed Corp develops, manufactures, markets and distributes Magnetic Resonance Imaging compatible products to acute care facilities and outpatient imaging centers, both in the United States and internationally. iRadimed Corp has a market cap of $137.218 million; its shares were traded at around $13.00 with a P/E ratio of 260.00 and P/S ratio of 6.49. iRadimed Corp had annual average EBITDA growth of 15.70% over the past five years.

For the last quarter iRadimed Corp reported a revenue of $6.71 million, compared with the revenue of $5.99 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $23.1 million, a decrease of 29% from the previous year. For the last five years iRadimed Corp had an average revenue growth rate of 30.7% a year.

The reported diluted earnings per share was 4 cents for the year, a decline of 93.3% from the previous year. Over the last five years iRadimed Corp had an average EPS decline of 2.7% a year. The iRadimed Corp had an operating margin of 5.57%, compared with the operating margin of 33.6% a year before. The 10-year historical median operating margin of iRadimed Corp is 22.09%. The profitability rank of the company is 8 (out of 10).

At the end of the fiscal year, iRadimed Corp has the cash and cash equivalents of $18.2 million, compared with $17.7 million in the previous year. The company had no long term debt. iRadimed Corp has a financial strength rank of 10 (out of 10).

At the current stock price of $13.00, iRadimed Corp is traded at close to its historical median P/S valuation band of $13.42. The P/S ratio of the stock is 6.49, while the historical median P/S ratio is 6.68. The stock gained 54.76% during the past 12 months.

For the complete 20-year historical financial data of IRMD, click here.

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

kislevamnonjames montier
kislevamnonhigh quality
maxerHK stocks price is 80% of EPV
maxerMorningstar wide moat
maxerUS & HK Healthcare - Price is
MYDemarayLow EV/EBITDA w/ Rev Growth
jkmarine.splprice below 50%
BNPEV:EBIT & P/FCF & >$100k volum
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat